If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
376.50    -4.50 (-1.18%)
Bid:
375.00
Ask:
377.50
Spread: 2.50 (0.667%)
Market Cap: £1.92b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

8 Jun 2017 14:31

RNS Number : 5776H
Caledonia Investments PLC
08 June 2017
Β 

Caledonia Investments plc

Director/PDMR Shareholding Notification

Β 

Caledonia Investments plc ("Caledonia") has been notified pursuant to the requirements of the EU Market Abuse Regulations of the following transactions involving three of its directors, Jamie Cayzer-Colvin, Stephen King and William Wyatt as detailed below.

Β 

On 6 June 2017, ordinary 5p shares were transferred to the above-named directors under Caledonia's 2011 Deferred Bonus Plan ("Deferred Bonus Plan") and 2011 Performance Share Scheme ("Performance Share Scheme"), at nil cost. On the same date, Mr Cayzer-Colvin exercised options under Caledonia's 2005 Executive Share Option Scheme ("Executive Share Option Scheme") at an exercise price of 1446p. All resulting shares were sourced from the Caledonia Investments plc Employee Share Trust and subsequently sold at 2910p per share on the same date.

Β 

Deferred Bonus Plan

No of shares transferred under the Deferred Bonus Plan at Β£nil

Β 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

Β 

11,302

0.02

11,302

SA King

13,365

0.02

13,365

WP Wyatt

Β 

18,837

0.03

18,837

Β 

Performance Share Scheme

No of shares transferred under the Performance Share Scheme at Β£nil

Β 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

Β 

19,749

0.04

19,749

SA King

11,194

0.02

11,194

WP Wyatt

Β 

15,776

0.03

15,776

Β 

Β 

Executive Share Option Scheme

No of options exercised under the Executive Share Option Scheme at 1446p

Β 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

12,707

0.02

12,707

Β 

Further information required by the EU Market Abuse Regulations in relation to these transactions is set out in the appendix below.

Enquiries:

Mrs K M Burwood

Deputy Company Secretary

Caledonia Investments plc

+ 44 20 7802 8080

8 June 2017

Β 

APPENDIXΒ 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

James Michael Beale Cayzer-Colvin

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Exercise of options with an exercise price of Β£14.46

3. Call of Deferred Bonus Plan ("DBP") awards

4. Sale of all shares

Β 

Β 

c)

Β 

Β 

Β 

Price(s) and volume(s)

Β 

Β 

1. Exercise of PSS awards

Β 

2. Exercise of options

Β 

3. Call of DBP awards

Β 

4. Sale of shares

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

19,749

Β 

Β£14.46

12,707

Β£0.00

11,302

Β£29.10

43,758

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

Β 

Β 

Β 

Β 

- Price

Β 

Β 

Β 

Β 

Exercise of PSS awards, exercise of options with an exercise price of Β£14.46 and call of DBP awards: 43,758

Β 

Sale of shares: 43,758

Β 

Exercise of PSS awards (Β£nil), exercise of options with an exercise price of Β£14.46 (Β£14.46) and call of DBP awards (Β£nil): weighted average price Β£4.20

Β 

Sale of shares: Β£29.10

Β 

e)

Β 

Date of the transaction

Β 

Β 

6 June 2017

f)

Β 

Place of the transaction

Β 

Β 

Exercise of PSS awards, options with an exercise price of Β£14.46 and call of DBP awards - outside a trading venue

Sale of shares - London Stock Exchange XLON

Β 

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Stephen Anthony King

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares

Β 

Β 

Price(s) and volume(s)

Β 

Β 

Β 

1. Exercise of PSS awards

Β 

2. Call of DBP awards

Β 

3. Sale of shares

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

11,194

Β 

Β£0.00

13,365

Β£29.10

24,559

Β 

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

Β 

Β 

Β 

- Price

Β 

Β 

Β 

Β 

Exercise of PSS awards and call of DBP awards: 24,559

Β 

Sale of shares: 24,559

Β 

Exercise of PSS awards and call of deferred shares: Β£nil

Β 

Sale of shares: Β£29.10

Β 

e)

Β 

Date of the transaction

Β 

Β 

6 June 2017

f)

Β 

Place of the transaction

Β 

Β 

Exercise of PSS awards and call of DBP awards - outside a trading venue

Β 

Sale of shares - London Stock Exchange XLON

Β 

Β 

Β 

Β 

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

William Penfold Wyatt

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares

Β 

c)

Β 

Β 

Price(s) and volume(s)

Β 

1. Exercise of PSS awards

Β 

2. Call of DBP awards

Β 

3. Sale of shares

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

15,776

Β 

Β£0.00

18,837

Β£29.10

34,613

Β 

Β 

Β 

Β 

Β 

d)

Β 

Β 

Β 

Β 

Aggregated information

Β 

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

Β 

Β 

Β 

Β 

Exercise of PSS awards and call of DBP awards: 34,613

Β 

Sale of shares: 34,613

Β 

Β 

Exercise of PSS awards and call of deferred shares: Β£nil

Β 

Sale of shares: Β£29.10

Β 

e)

Β 

Date of the transaction

Β 

Β 

6 June 2017

f)

Β 

Place of the transaction

Β 

Β 

Exercise of PSS awards and call of DBP awards - outside a trading venue

Β 

Sale of shares - London Stock Exchange XLON

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHSSUFDAFWSEEM
Date   Source Headline
1st Jun 20205:20 pmRNSDirector/PDMR Shareholding
27th May 20207:00 amRNSFinal Results
19th May 20205:28 pmRNSDirector Declaration
7th May 20209:08 amRNSNet Asset Value(s)
30th Apr 20204:26 pmRNSDirector Declaration
28th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Apr 20206:06 pmRNSDisclosure of rights attached to equity shares
7th Apr 20207:00 amRNSNet Asset Value(s)
30th Mar 20203:37 pmRNSHolding(s) in Company
20th Mar 20204:41 pmRNSPrice Monitoring Extension
20th Mar 202010:10 amRNSHolding(s) in Company
5th Mar 202011:24 amRNSNet Asset Value(s)
6th Feb 202010:47 amRNSNet Asset Value(s)
7th Jan 20209:53 amRNSNet Asset Value(s)
2nd Jan 20208:00 amRNSBlock listing Interim Review
20th Dec 20199:43 amRNSCompany Secretary Change
17th Dec 20198:05 amRNSDirector/PDMR Shareholding
6th Dec 201910:23 amRNSNet Asset Value(s)
28th Nov 201910:05 amRNSDirector/PDMR Shareholding
26th Nov 20197:00 amRNSHalf-year Report
22nd Nov 20193:40 pmRNSDirector Declaration
7th Nov 20199:13 amRNSNet Asset Value(s)
29th Oct 20199:30 amRNSDirector Declaration
7th Oct 201911:33 amRNSNet Asset Value(s)
30th Sep 20193:39 pmRNSHolding(s) in Company
30th Sep 20193:20 pmRNSTransaction in Own Shares
26th Sep 20191:19 pmRNSShare Purchase by Caledonia Employee Share Trust
6th Sep 201912:14 pmRNSNet Asset Value(s)
7th Aug 20199:47 amRNSNet Asset Value(s)
24th Jul 20191:08 pmRNSResult of AGM
10th Jul 20199:00 amRNSAcquisition
4th Jul 20193:29 pmRNSNet Asset Value(s)
1st Jul 20197:00 amRNSBlock listing Interim Review
18th Jun 20198:40 amRNSAnnual Financial Report
10th Jun 20198:09 amRNSDirectorate Change
6th Jun 20191:10 pmRNSNet Asset Value(s)
31st May 20191:52 pmRNSDirector/PDMR Shareholding
29th May 20198:04 amRNSHolding(s) in Company
29th May 20197:00 amRNSFinal Results
7th May 20191:59 pmRNSNet Asset Value(s)
26th Apr 20192:46 pmRNSHolding(s) in Company
5th Apr 201910:55 amRNSNet Asset Value(s)
29th Mar 201912:35 pmRNSLetter to Shareholders - Electronic Communications
29th Mar 201912:15 pmRNSTransaction in Own Shares
6th Mar 20198:23 amRNSNet Asset Value(s)
6th Feb 20193:57 pmRNSNet Asset Value(s)
29th Jan 20199:24 amRNSDirector/PDMR Shareholding
16th Jan 20192:04 pmRNSDirector/PDMR Shareholding
8th Jan 20193:40 pmRNSDirector/PDMR Shareholding
8th Jan 201910:02 amRNSReport for the quarter ended 31 December 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.